{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:39:43Z","timestamp":1790703583654,"version":"4.1.0"},"reference-count":31,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Oncol"],"DOI":"10.3892\/ijo.2019.4761","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T12:16:36Z","timestamp":1553256996000},"source":"Crossref","is-referenced-by-count":21,"title":["Immunoglobulin\u2011like transcript 4 and human leukocyte antigen\u2011G interaction promotes the progression of human colorectal cancer"],"prefix":"10.3892","author":[{"given":"Zhaoyang","family":"Cai","sequence":"first","affiliation":[{"name":"School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Qilu Hospital of Shan\u2011dong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rumei","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingliang","family":"Zhu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwen","family":"Yu","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"key20200713185756_b1-ijo-54-06-1943","first-page":"5933","article-title":"High expression of estrogen related receptor \u03b1 is signifi cantly associated with poor prognosis in patients with colorectal cancer","volume":"15","author":"Liang","year":"2018","journal-title":"Oncol Lett"},{"key":"key20200713185756_b2-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"key20200713185756_b3-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/ecc.12287","article-title":"Cancer in the elderly in the Czech Republic","volume":"24","author":"Petera","year":"2015","journal-title":"Eur J Cancer Care (Engl)"},{"key":"key20200713185756_b4-ijo-54-06-1943","first-page":"4855","article-title":"Differential expression and prognostic role of selected genes in colorectal cancer patients","volume":"33","author":"Pitule","year":"2013","journal-title":"Anticancer Res"},{"key":"key20200713185756_b5-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/smim.2000.0214","article-title":"A family of inhibitory and activating Ig like receptors that modulate function of lymphoid and myeloid cells","volume":"12","author":"Colonna","year":"2000","journal-title":"Semin Immunol"},{"key":"key20200713185756_b6-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1359-6101(00)00007-1","article-title":"LIRs\/ILTs\/MIRs, inhibitory and stimulatory Ig superfamily receptors expressed in myeloid and lymphoid cells","volume":"11","author":"Borges","year":"2000","journal-title":"Cytokine Growth Factor Rev"},{"key":"key20200713185756_b7-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"8856","DOI":"10.1073\/pnas.1431057100","article-title":"Human inhibitory receptors Ig like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G","volume":"100","author":"Shiroishi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185756_b8-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.4049\/jimmunol.171.12.6611","article-title":"Transcriptional regulation of ILT family receptors","volume":"171","author":"Nakajima","year":"2003","journal-title":"J Immunol"},{"key":"key20200713185756_b9-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1378\/chest.07-1100","article-title":"Expression of Ig like transcript 4 inhibitory receptor in human non small cell lung cancer","volume":"134","author":"Sun","year":"2008","journal-title":"Chest"},{"key":"key20200713185756_b10-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1746-1596-9-85","article-title":"Inhibitory receptor immunoglobulin like transcript 4 was highly expressed in primary ductal and lobular breast cancer and significantly correlated with IL 10","volume":"9","author":"Liu","year":"2014","journal-title":"Diagn Pathol"},{"key":"key20200713185756_b11-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1007\/s13277-016-5002-5","article-title":"Co expression of ILT4\/HLA-G in human non small cell lung cancer correlates with poor prognosis and ILT4 HLA-G interaction activates ERK signaling","volume":"37","author":"Zhang","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200713185756_b12-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3389\/fimmu.2014.00652","article-title":"HLA Class Ib Molecules and Immune Cells in Pregnancy and Preeclampsia","volume":"5","author":"Djurisic","year":"2014","journal-title":"Front Immunol"},{"key":"key20200713185756_b13-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1096\/fj.04-1617fje","article-title":"HLA-G up regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells","volume":"19","author":"LeMaoult","year":"2005","journal-title":"FASEB J"},{"key":"key20200713185756_b14-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/eji.201646564","article-title":"HLA-G promotes myeloid derived suppressor cell accumulation and suppressive activity during human pregnancy through engagement of the receptor ILT4","volume":"47","author":"K\u00f6stlin","year":"2017","journal-title":"Eur J Immunol"},{"key":"key20200713185756_b15-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"359748","DOI":"10.1155\/2014\/359748","article-title":"The dual role of HLA-G in cancer","volume":"2014","author":"Rouas Freiss","year":"2014","journal-title":"J Immunol Res"},{"key":"key20200713185756_b16-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"e1342023","DOI":"10.1080\/2162402X.2017.1342023","article-title":"Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G\/ILT2\/ILT4","volume":"6","author":"Rouas Freiss","year":"2017","journal-title":"OncoImmunology"},{"key":"key20200713185756_b17-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.anndiagpath.2016.09.012","article-title":"A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues","volume":"25","author":"\u00d6zg\u00fcl \u00d6zdemir","year":"2016","journal-title":"Ann Diagn Pathol"},{"key":"key20200713185756_b18-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1007\/s00018-017-2712-9","article-title":"Early SIV and HIV infection promotes the LILRB2\/MHC I inhibitory axis in cDCs","volume":"75","author":"Alaoui","year":"2018","journal-title":"Cell Mol Life Sci"},{"key":"key20200713185756_b19-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00005-017-0474-6","article-title":"KIR, LILRB and their Ligands\u2019 Genes as Potential Biomarkers in Recurrent Implantation Failure","volume":"65","author":"Nowak","year":"2017","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"key20200713185756_b20-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"4163094","DOI":"10.1155\/2016\/4163094","article-title":"Analysis of the Expression and Function of Immunoglobulin Like Transcript 4 (ILT4, LILRB2) in Dendritic Cells from Patients with Systemic Lupus Erythematosus","volume":"2016","author":"Guerra de Blas","year":"2016","journal-title":"J Immunol Res"},{"key":"key20200713185756_b21-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key20200713185756_b22-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real time quantitative PCR and the 2(Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200713185756_b23-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.bbcan.2018.04.001","article-title":"ILT4 functions as a potential checkpoint molecule for tumor immunotherapy","volume":"1869","author":"Gao","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"key20200713185756_b24-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/TP.0b013e31821414c9","article-title":"HLA-G level on monocytoid dendritic cells correlates with regulatory T cell Foxp3 expression in liver transplant tolerance","volume":"91","author":"Castellaneta","year":"2011","journal-title":"Transplantation"},{"key":"key20200713185756_b25-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.1073\/pnas.0803341105","article-title":"Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL 6 STAT3 signaling pathway","volume":"105","author":"Liang","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713185756_b26-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.humimm.2006.11.008","article-title":"Mechanisms of prolongation of allograft survival by HLA-G\/ILT4 modified dendritic cells","volume":"68","author":"Ristich","year":"2007","journal-title":"Hum Immunol"},{"key":"key20200713185756_b27-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: An Immune Checkpoint Molecule","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"key":"key20200713185756_b28-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.it.2008.02.012","article-title":"A critical look at HLA-G","volume":"29","author":"Apps","year":"2008","journal-title":"Trends Immunol"},{"key":"key20200713185756_b29-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/bjc.2013.696","article-title":"Combined analysis of HLA class I, HLA E and HLA-G predicts prognosis in colon cancer patients","volume":"110","author":"Zeestraten","year":"2014","journal-title":"Br J Cancer"},{"key":"key20200713185756_b30-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellimm.2014.10.003","article-title":"Predictive value of HLA-G and HLA E in the prognosis of colorectal cancer patients","volume":"293","author":"Guo","year":"2015","journal-title":"Cell Immunol"},{"key":"key20200713185756_b31-ijo-54-06-1943","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/1471-2407-14-486","article-title":"Prognostic value of HLA class I, HLA E, HLA-G and Tregs in rectal cancer: A retrospective cohort study","volume":"14","author":"Reimers","year":"2014","journal-title":"BMC Cancer"}],"container-title":["International Journal of Oncology"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:04:10Z","timestamp":1594667050000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijo.2019.4761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":31,"URL":"https:\/\/doi.org\/10.3892\/ijo.2019.4761","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]}}}